List view / Grid view
9 June 2015 | By Coulter Partners
Coulter Partners is pleased to announce the appointment of Shawn O’Connor as a Managing Director of their US business...
9 June 2015 | By NICE
NICE has recommended the anti-blood clotting drug apixaban as an option for treating and preventing venous thromboembolism (VTE) in adults...
9 June 2015 | By Victoria White
Carbylan Therapeutics has completed enrollment of its COR1.1 Phase 3 pivotal trial of Hydros-TA for the treatment of pain associated with osteoarthritis...
9 June 2015 | By Victoria White
Johnson & Johnson and a group of leading research organisations are launching the OPTICS Project - Open Translational Science in Schizophrenia...
9 June 2015 | By Victoria White
UBM EMEA announced the findings of the Pharma Insights Turkey 2015 report, a comprehensive review of the Turkish pharma market, at CPhI Istanbul...
9 June 2015 | By Victoria White
Results of the ELIXA study assessing the cardiovascular safety of lixisenatide in adults with type 2 diabetes and high CV risk have been presented...
9 June 2015 | By Victoria White
Cost-containment measures are shifting the decision-making focus of North America’s pharmaceutical market from the prescriber to the payer, says GlobalData...
9 June 2015 | By Victoria White
Lenvima launches in the UK today as a treatment option for people with radioactive iodine refractory differentiated thyroid cancer (RAI refractory DTC)...
8 June 2015 | By Victoria White
BioMarin has submitted a MAA for drisapersen for the treatment of the largest subset of Duchenne muscular dystrophy (DMD) amenable to single exon skipping...
8 June 2015 | By Victoria White
WHO and the Republic of Korea’s Ministry of Health and Welfare are to conduct a joint mission in the Republic of Korea to better understand MERS-CoV...
8 June 2015 | By Victoria White
A Phase II clinical trial testing the ability of the generic vaccine BCG to reverse advanced type 1 diabetes has received approval from the FDA...
8 June 2015 | By Victoria White
Lilly’s basal insulin peglispro has consistently demonstrated superior HbA1c reduction in people with type 2 diabetes compared to insulin glargine in trials...
8 June 2015 | By Victoria White
Mylan has launched the first bioequivalent alternative to GlaxoSmithKline's Seretide Evohaler under the brand name Sirdupla in the UK...
8 June 2015 | By Victoria White
Sanofi has announced results from two extension studies where participants with diabetes received Toujeo or Lantus treatment for a total of 12 months...
8 June 2015 | By Victoria White
The National Institute for Health and Care Excellence (NICE) has launched public consultations on draft recommendations for two prostate cancer drugs...
